search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Alkermes plc

    (NASDAQ:ALKS)

    $29.56

    $1.49

    5.31%

    Alkermes plc Chart

    ALKS Stock Price Today

    Alkermes plc (ALKS) stock rallied over 5.31% intraday to trade at $29.56 a share on NASDAQ. The stock opened with a gain of 7.69% at $28.19 and touched an intraday high of $29.7, rising 5.31% against the last close of $28.07. The stock went to a low of $28.15 during the session.

    Stock Snapshot

    $28.07

    Prev. Close

    4.68 Billion

    Market Cap

    $28.15

    Day Low

    $28.19

    Open

    162.48 Million

    Number of Shares

    $29.7

    Day High

    -

    P/E ratio

    -0.38

    EPS (TTM)

    3.24

    Cash Flow per Share

    4.04

    Free Float in %

    6.78

    Book Value

    1,303,788

    Volume

    Alkermes plc Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$28.19$29.7$28.15$29.561,305,700
    2022-06-22$27.45$28.69$27.28$28.071,725,100
    2022-06-21$28.42$28.62$27.62$27.651,281,000
    2022-06-17$27.31$28.86$27.31$28.033,245,500
    2022-06-16$27.04$27.49$26.74$27.011,101,700
    2022-06-15$27.38$27.79$26.99$27.63753,200
    2022-06-14$27.46$27.62$26.59$27.19900,600
    2022-06-13$26.82$27.36$26.6$27.341,155,200
    2022-06-10$27.55$27.77$27.09$27.461,327,000
    2022-06-09$29.5$29.58$28.1$28.13757,500

    Contact Details

    Connaught House
    1 Burlington Road
    Dublin 4
    Ireland

    Webiste:ALKS

    353 1 772 8000

    Company Information

    Employees-

    Beta0.75

    Sales or Revenue1.2 Billion

    5Y Sales Change9.50%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an extended-release intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia; and VUMERITY (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI (olanzapine/samidorphan), an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International; a license agreement with Acorda Therapeutics, Inc.; and a license and collaboration agreement with Biogen Swiss Manufacturing GmbH. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

    Frequently Asked Questions

    icon

    What is the current Alkermes plc (ALKS) stock price?

    Alkermes plc (NASDAQ: ALKS) stock price is $29.56 as of the last check on Thursday, June 23. During the trading session, ALKS stock reached the peak price of $29.7 while $28.15 was the lowest point it dropped to.

    icon

    ALKS's industry and sector of operation?

    The NASDAQ listed ALKS is part of Biotechnology industry that operates in the broader Health Care sector. Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an extended-release intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia; and VUMERITY (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases.

    icon

    Who are the executives of ALKS?

    Mr. Peter Norman
    Sr. VP of Policy & Gov. Relations
    Mr. Richard F. Pops
    Chairman & CEO
    Mr. David Joseph Gaffin
    Sr. VP, Chief Legal Officer, Chief Compliance Officer & Sec.
    Mr. Michael J. Landine
    Sr. VP of Corp. Devel. & Chief Risk Officer

    icon

    What is the ALKS stock price today?

    ALKS stock traded closed the last session at $29.56, which is $1.49 or 5.31% lower than its previous close of $28.07. ALKS's current trading price is 39.17% lower than its 52-week high of $33.00 where as its distance from 52-week low of 21.24% is -10.42%.

    icon

    How many employees does ALKS have?

    Number of ALKS employees currently stands at -. ALKS operates from Connaught House, 1 Burlington Road, Dublin 4, Ireland.

    icon

    Link for ALKS official website?

    Official Webiste of $ALKS is: https://www.alkermes.com

    icon

    How do I contact ALKS?

    ALKS could be contacted at ALKS operates from Connaught House, 1 Burlington Road, Dublin 4, Ireland, or at phone #353 1 772 8000 and can also be accessed through its website.

    icon

    How many shares of ALKS are traded daily?

    ALKS stock volume for the day was 1,303,788 shares while in the previous session number of ALKS shares traded was 1,305,700 . The average number of ALKS shares traded daily for last 3 months was 1.62 Million.

    icon

    How much did ALKS change today?

    The percentage change in ALKS stock occurred in the recent session was 5.31% while the dollar amount for the price change in ALKS stock was $1.49.

    icon

    What price range ALKS stock been trading in?

    In the recent session, the day high for ALKS stock was $29.7 while the low for ALKS stock touched on the day was $28.15.

    icon

    What is the market cap of ALKS currently?

    The market value of ALKS currently stands at 4.68 Billion with its latest stock price at $29.56 and 162.48 Million of its shares outstanding.